The interferon-alpha signature of systemic lupus erythematosus.
The interferon-alpha signature of systemic lupus erythematosus.
复制标题
DOI:
10.1177/0961203310371161
复制
发表时间:
2010-08
期刊:
影响因子:
2.6
通讯作者:
Pascual V
中科院分区:
文献类型:
--
作者:
Obermoser G;Pascual V
Systemic lupus erythematosus (SLE) is a prototypic multisystem autoimmune disorder where interplay of environmental and genetic risk factors leads to progressive loss of tolerance to nuclear antigens over time, finally culminating in clinical disease. The heterogeneity of clinical manifestations and the disease’s unpredictable course characterized by flares and remissions are very likely a reflection of heterogeneity at the origin of disease, with a final common pathway leading to loss of tolerance to nuclear antigens. Impaired clearance of immune complexes and apoptotic material and production of autoantibodies have long been recognized as major pathogenic events in this disease. Over the past decade the type I interferon cytokine family has been postulated to play a central role in SLE pathogenesis, by promoting feedback loops progressively disrupting peripheral immune tolerance and driving disease activity. The identification of key molecules involved in the pathogenesis of SLE will not only improve our understanding of this complex disease, but also help to identify novel targets for biological intervention.
登录
查看更多内容
影响因子:
12.8
作者:
Cederblad, B;Blomberg, S;Ronnblom, L
通讯作者:
Ronnblom, L
影响因子:
5
作者:
Graham, D. S. Cunninghame;Vyse, T. J.;Rioux, J. D.
通讯作者:
Rioux, J. D.
影响因子:
158.5
作者:
Arbuckle, MR;McClain, MT;Harley, JB
通讯作者:
Harley, JB
影响因子:
15.3
作者:
Ehrenstein, MR;Evans, JG;Singh, A;Moore, S;Warnes, G;Isenberg, DA;Mauri, C
通讯作者:
Mauri, C
DOI:
10.1084/jem.20021553
发表时间:
2003-03-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bennett L;Palucka AK;Arce E;Cantrell V;Borvak J;Banchereau J;Pascual V
通讯作者:
Pascual V